Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial

Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies

(2021) Dawn S. Milliner et al.   PEDIATRIC NEPHROLOGY

Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1

(2021) Yaacov Frishberg et al.   Clinical Journal of the American Society of Nephrology

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

(2021) Sander F. Garrelfs et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liver Transplantation in Primary Hyperoxaluria Type 1: We Have to Find an Alternative!

(2021) Arnaud Devresse et al.   TRANSPLANTATION

Primary hyperoxaluria diagnosed after kidney transplant: A review of the literature and case report of aggressive renal replacement therapy and lumasiran to prevent allograft loss

(2021) Hillarey K. Stone et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children

(2021) David J. Sas et al.   GENETICS IN MEDICINE

Endpoints for Clinical Trials in Primary Hyperoxaluria

(2020) Dawn S. Milliner et al.   Clinical Journal of the American Society of Nephrology

Primary Hyperoxaluria

(2020) Jennifer E. Lawrence et al.   Clinical Journal of the American Society of Nephrology

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort

(2020) Ronak Jagdeep Shah et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Plasma oxalate levels in primary hyperoxaluria type I show significant intra-individual variation and do not correlate with kidney function

(2020) Philip Hillebrand et al.   PEDIATRIC NEPHROLOGY

KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation

(2020) Steven J. Chadban et al.   TRANSPLANTATION

Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria

(2020) Tracy L McGregor et al.   eLife

Plasma oxalate: comparison of methodologies

(2020) Felicity Stokes et al.   Urolithiasis

Transplantation for hyperoxaluria type 1: designing new strategies in the era of promising therapeutic perspectives

(2020) Arnaud Devresse et al.   Kidney International Reports

Glycolate oxidase deficiency in a patient with congenital hyperinsulinism and unexplained hyperoxaluria

(2017) Oliver Clifford-Mobley et al.   PEDIATRIC NEPHROLOGY

An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria

(2016) Abigail Liebow et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria

(2015) K. Hopp et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Oxalate Quantification in Hemodialysate to Assess Dialysis Adequacy for Primary Hyperoxaluria

(2014) Xiaojing Tang et al.   AMERICAN JOURNAL OF NEPHROLOGY

Sustained Pyridoxine Response in Primary Hyperoxaluria Type 1 Recipients of Kidney Alone Transplant

(2014) E. C. Lorenz et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Mutations inHAO1encoding glycolate oxidase cause isolated glycolic aciduria

(2014) Yaacov Frishberg et al.   JOURNAL OF MEDICAL GENETICS

Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type

(2014) Giorgia Mandrile et al.   KIDNEY INTERNATIONAL

Primary Hyperoxaluria

(2013) Pierre Cochat et al.   NEW ENGLAND JOURNAL OF MEDICINE

Primary hyperoxaluria Type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort

(2012) S. M. van der Hoeven et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment

(2012) P. Cochat et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Transplantation Outcomes in Primary Hyperoxaluria

(2010) E. J. Bergstralh et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group

(2010) W. van Biesen et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

New Equations to Estimate GFR in Children with CKD

(2009) G. J. Schwartz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome

(2009) Jérôme Harambat et al.   KIDNEY INTERNATIONAL